Antibiotic Envelope Makes Device Implantation Safer

Now there’s less risk of infection from getting a pacemaker or defibrillator.

Every year 1 to 1.5 million people receive a cardiac implantable electronic device (CIED)—a pacemaker, biventricular pacemaker or implantable cardioverter-defibrillator—to help manage their heart rhythm. Despite the use of sterile technique and pre-procedure antibiotics, 1% to 4% of patients develop an infection from the device. Today, an absorbable antibiotic envelope is helping to prevent such infections. […]
To continue reading this article or issue you must be a paid subscriber. Sign in

Subscribe to Heart Advisor

Get the next year of Heart Advisor for just $20. And access all of our online content - over 2,000 articles - free of charge.
Subscribe today and save 38%. It's like getting 5 months FREE!
Already Subscribed?
Click Here to Sign In | Forgot your password? | Activate Web Access